Clinical Trials Directory

Trials / Completed

CompletedNCT02566902

Comparison of Breath-Enhanced and T-Piece Nebulizers in Children With Acute Asthma

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
118 (actual)
Sponsor
Seton Healthcare Family · Academic / Other
Sex
All
Age
6 Years – 17 Years
Healthy volunteers
Not accepted

Summary

This is a blinded observer randomized controlled trial comparing two nebulizer devices. The objective of this study is to evaluate the efficacy of two different nebulizers.

Detailed description

The investigators hypothesize that albuterol delivered with a breath-enhanced nebulizer will lead to statistically greater improvement in FEV1 when compared to an equivalent dose delivered via a standard t-piece nebulizer. The primary aim will be to study changes in forced expiratory volume in one second (FEV1) in patients presenting to an urban pediatric emergency department with a moderate to severe acute asthma exacerbation when utilizing these two nebulizers. Secondary aims will include evaluation of hospital admission rates, emergency department (ED) length of stay (LOS), changes in asthma severity scores, vital sign changes, medication side effects, and total quantity of albuterol given in the ED. A distal aim of the study will be to perform a cost analysis; though the investigators will likely need further clinical trials utilizing multiple dose administration in order to accurately analyze cost.

Conditions

Interventions

TypeNameDescription
DEVICET-Piece NebulizerAlbuterol treatment administered with Hudson RCI® Micro Mist® nebulizer (Teleflex Medical®, Research Triangle Park, NJ)
DEVICEBreath-Enhanced NebulizerAlbuterol treatment administered with NebuTech® HDN®, Breath-Enhanced High Density Jet Nebulizer (Salter Labs®, Arvin, CA)
DRUGAlbuterolOne time 5mg nebulized albuterol treatment given with one of two devices over 10 minutes.
PROCEDUREPre-Treatment Spirometry MeasurementBedside spirometry measurements taken prior to albuterol therapy using ndd® EasyOne Plus® spirometer.
PROCEDUREPost-Treatment Spirometry MeasurementBedside spirometry measurements taken after albuterol therapy using ndd® EasyOne Plus® spirometer.

Timeline

Start date
2015-10-01
Primary completion
2017-06-30
Completion
2017-06-30
First posted
2015-10-02
Last updated
2021-05-06
Results posted
2021-05-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02566902. Inclusion in this directory is not an endorsement.